Innoviva, Inc.
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1080014. Latest Form 4 filed Jan 13, 2023.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Armata Pharmaceuticals, Inc.ARMP | Director, 10% owner | 10 | 2021-01-26 | 2023-01-10 |
| Armata Pharmaceuticals, Inc.ARMP | 10% owner | 2 | 2020-03-27 | 2020-03-27 |
Transactions: 12
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2023-01-10 | Armata Pharmaceuticals, Inc.Director, 10% owner | PurchaseConvertible Debt convertible into Common Stock | not reported | $30,000,000.00 | not reported | Form 4 |
| 2022-03-31 | Armata Pharmaceuticals, Inc.Director, 10% owner | PurchaseWarrants to Purchase Common Stock | 0 | $5.00 | $0 | Form 4 |
| 2022-03-31 | Armata Pharmaceuticals, Inc.Director, 10% owner | Purchase | 5,385,208 | $5.00 | $26.9m | Form 4 |
| 2022-02-09 | Armata Pharmaceuticals, Inc.Director, 10% owner | PurchaseWarrants to Purchase Common Stock | 1,807,396 | $5.00 | $9.0m | Form 4 |
| 2022-02-09 | Armata Pharmaceuticals, Inc.Director, 10% owner | Purchase | 3,614,792 | $5.00 | $18.1m | Form 4 |
| 2021-10-29 | Armata Pharmaceuticals, Inc.Director, 10% owner | Purchase | 1,212,122 | $3.30 | $4.0m | Form 4 |
| 2021-03-17 | Armata Pharmaceuticals, Inc.Director, 10% owner | PurchaseWarrants to Purchase Common Stock | 4,285,935 | $3.25 | $13.9m | Form 4 |
| 2021-03-17 | Armata Pharmaceuticals, Inc.Director, 10% owner | Purchase | 4,285,935 | $3.25 | $13.9m | Form 4 |
| 2021-01-26 | Armata Pharmaceuticals, Inc.Director, 10% owner | PurchaseWarrants to Purchase Common Stock | 1,867,912 | $3.25 | $6.1m | Form 4 |
| 2021-01-26 | Armata Pharmaceuticals, Inc.Director, 10% owner | Purchase | 1,867,912 | $3.25 | $6.1m | Form 4 |
| 2020-03-27 | Armata Pharmaceuticals, Inc.10% owner | PurchaseWarrants to Acquire Common Stock | 7,717,661 | $2.87 | $22.1m | Form 4 |
| 2020-03-27 | Armata Pharmaceuticals, Inc.10% owner | Purchase | 7,717,661 | $2.87 | $22.1m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 22:38 ET. Listed shows no prices and gives no investment advice.